These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7868374)

  • 1. Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.
    Olson RR; Reuter JJ; McNicholl J; Alber C; Klohe E; Callahan K; Siliciano RF; Karr RW
    Hum Immunol; 1994 Nov; 41(3):193-200. PubMed ID: 7868374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.
    Fu XT; Bono CP; Woulfe SL; Swearingen C; Summers NL; Sinigaglia F; Sette A; Schwartz BD; Karr RW
    J Exp Med; 1995 Mar; 181(3):915-26. PubMed ID: 7869051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
    Olson RR; De Magistris MT; Di Tommaso A; Karr RW
    J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
    Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
    Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.
    Fu XT; Karr RW
    Hum Immunol; 1994 Apr; 39(4):253-60. PubMed ID: 7520896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions in the HLA-DR alpha chain differentially affect DR7-restricted T-cell recognition of rabies virus antigen.
    Fu XT; Saibara T; Karr RW; Celis E
    Hum Immunol; 1996 Feb; 45(2):111-6. PubMed ID: 8882408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of TCR-alpha beta sequences of cross-reactive anti-DR alloreactive T-cell clones: identification of possible contact residues based on charge complementarity between TCR chains and DR determinants.
    Champagne E; Essaket S; Huchenq A; Fabron J; Coppin HL; Sevin J; Thomsen M
    Eur J Immunogenet; 1992; 19(1-2):21-31. PubMed ID: 1533151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen processing and presentation by a mouse macrophage-like cell line expressing human HLA class II molecules.
    Daubenberger C; Lang B; Nickel B; Willcox N; Melchers I
    Int Immunol; 1996 Mar; 8(3):307-315. PubMed ID: 8671616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-Dw14 and HLA-DR3 haplotypes share a functional determinant recognized by a human alloreactive T-cell clone.
    Lang B; LoGalbo PR; Sanchez B; Winchester R
    Hum Immunol; 1988 Sep; 23(1):59-70. PubMed ID: 2461353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of residues involved in polymorphic antibody binding epitopes on HLA-DR molecules.
    Fu XT; Yu WY; Alber C; Benson C; Watts R; Nordwig H; Johnson JP; Knowles RW; Karr RW
    Hum Immunol; 1992 Jan; 33(1):47-56. PubMed ID: 1372304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
    Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
    J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.
    Wucherpfennig KW; Yu B; Bhol K; Monos DS; Argyris E; Karr RW; Ahmed AR; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11935-9. PubMed ID: 8524878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
    Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
    J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S; Yu WY; Karr RW
    J Immunol; 1991 Jun; 146(12):4264-70. PubMed ID: 2040801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes.
    Klohe E; Fu XT; Ballas M; Karr RW
    Hum Immunol; 1993 May; 37(1):51-8. PubMed ID: 7690741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.